New glasses could slow Kids' worsening eyesight

NCT ID NCT06263946

Ongoing Disease control Sponsor: Essilor International Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether Essilor Stellest spectacle lenses can slow the progression of myopia (nearsightedness) in children and teens aged 6 to 16. One hundred fifty participants will wear the lenses for at least 12 hours a day over 24 months. Researchers will measure changes in eye length and prescription strength to see if the lenses work better than expected natural progression.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Essilor Stellest spectacle lenses
What this could lead to: If successful, these lenses could offer a simple, non-invasive way to slow worsening nearsightedness in children, reducing the need for stronger prescriptions.
What could go wrong: This is a post-market study with no control group, so results may be less definitive. The lenses require full-time wear for 2 years, and not all children may see the same benefit.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MYOPIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

myopia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

MYOPIA

Contacts and locations

Locations

Centre for Eye Research Ireland (CERI) - TU DUBLIN

Dublin, D07 H6K8, Ireland
Erasmus Medical Center

Rotterdam, 3015, Netherlands
Hôpital Fondation Adolphe de Rothschild - Ophthalmology Department

Paris, 75019, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.